Pacific Biosciences Of California | PACB - Operating Profit


Pacific Biosciences Of California reported $-53.19M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Agilent USD 353M 90M Dec/2025
Bruker USD 76.3M 7.6M Dec/2025
Danaher USD 1.5B 348M Dec/2025
General Electric Aerospace USD 1.77B 536M Dec/2025
Illumina USD 256M 6M Dec/2025
Myriad Genetics USD -3M 20.3M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quidel USD -37.3M 667.5M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Standard Biotools USD -21.92M 1.55M Dec/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Waters USD 270.52M 78.4M Dec/2025